Patients diagnosed with Burkitt lymphoma at Strasbourg University Hospitals between January 1, 2009, and December 31, 2025, and/or managed by the Hematology Department of Strasbourg University Hospitals or ICANS for Burkitt lymphoma during this period.
No written objection documented in the medical record to the reuse of personal data for scientific research.
You may not be if
Patients who have objected to the reuse of their personal data for scientific research.
Patients diagnosed with another B-cell non-Hodgkin lymphoma other than Burkitt lymphoma.
Patients for whom accessible data are unavailable.
Individuals under legal protection (sauvegarde de justice).
Individuals under guardianship or curatorship (tutelle or curatelle).
Clareo Health | Toxicity of Intensive First-Line Treatment for Adult Burkitt Lymphoma: A Retrospective Observational Study
